Hit to trading terms

Wholesalers forced to act in the wake of direct distribution defections The recent moves by manufacturers AstraZeneca and Amgen to a direct distribution model are being blamed for driving full-line wholesalers to reduce their trading terms to pharmacies. Earlier this week industry newsletter Pharma In Focus reported that Sigma was believed to be winding back